Latest Salt News

BCI Minerals has pushed the Mardie project to 90% construction completion, while crystallised salt rose more than fivefold to 266,000 tonnes during the September quarter. The company still targets first salt on ship in calendar 2027, but the timetable depends on summer evaporation and the final commissioning push.

Everest Metals has advanced its Mt Edon rubidium project towards pilot plant development after batch testing delivered recovery of up to 90% and cut leaching water use by 60%. The scale-up remains unfinished, with continuous rotary-kiln trials producing lower and variable recovery of 50% to 60%.

Vanadium Resources has repositioned its Steelpoortdrift project around a proposed V-Iron plant producing pig iron and vanadium-bearing slag for Western markets. The strategy has secured a non-binding U.S. offtake framework and advanced site and funding work, but the auditor has flagged material uncertainty over the company’s ability to continue as a going concern.

Parkway Corporate Limited (ASX:PWN) delivered a sharp revenue increase in FY26 and generated positive operating cash flow, but slipped into a statutory loss and flagged significant uncertainty around its ability to continue as a going concern. Key approvals for its Queensland brine project and a new $2 million mining contract offer commercial progress, while funding remains the central test.

Vanadium Resources has secured an oversubscribed A$1.0 million placement to advance studies, site work, offtake discussions and project financing for its planned V-Iron Plant in South Africa. The raise gives VR8 fresh development capital, but the project still depends on a scoping study, binding commercial agreements and a much larger funding package.

Anson Resources has confirmed a 2,500-metre extension of uranium-vanadium mineralization at its Yellow Cat Project in Utah, with assay results indicating proximity to high-grade zones. Phase 2 drilling and environmental surveys are underway to upgrade a historical resource to JORC 2012 standards.

Parkway Corporate has cleared major regulatory hurdles for its Queensland Brine Management Complex, the first Australian facility authorised to convert coal seam gas waste brine into industrial chemicals, setting a new benchmark in sustainable waste management.

BCI Minerals edges closer to first salt shipment at its Mardie Project, with crystallisation underway and 85% construction complete. The company maintains full funding and advances its sulphate of potash opportunity alongside robust sustainability initiatives.

BCI Minerals has contracted Bluestar Lehigh to build a 150 kg/hr sulphate of potash pilot plant at Mardie, aiming to de-risk commercial SOP production. Commissioning is set for early FY2028 with piloting to span about a year, funded within the existing $1.443 billion Mardie budget.

American Rare Earths has partnered with Novex to tackle the critical oxide-to-metal bottleneck in the US rare earth supply chain, aiming to establish a fully domestic mine-to-magnet value chain from its Halleck Creek Project.

Alterity Therapeutics has won a new US composition of matter patent for its lead drug ATH434, extending intellectual property protection to at least 2045 and boosting its commercial potential ahead of Phase 3 trials in Multiple System Atrophy.

Mount Ridley Mines’ first TIMA automated mineralogy study at Grass Patch reveals rare earth elements are locked in discrete phosphate minerals, supporting flotation as a key beneficiation step ahead of leaching and Phase 1 metallurgical testwork.